Axsome Corp (AXSM) Stock Quotes

Axsome Therapeutics (AXSM) possesses significant pricing power through the development of new drug combinations for CNS therapy, where demand remains stable. This chart of share prices is supported by revenue from migraine and depression treatments covered by private funds and government insurance, with the metric standing at 140.73. Automated packaging systems and digital analysis of clinical data further support business growth.

Market Chart: Axsome Therapeutics (AXSM) for 07/04/2022 - 11/11/2026

Axsome (AXSM) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Price Axsome Therapeutics|AXSM - Analyst Consensus Forecast

- market capitalization details:

Market Valuation Axsome|AXSM - Business Value

- issuer book value statistics:

Net Assets per Single Share Axsome Therapeutics|AXSM - Book Valuation of Business|Market Value to Book Value Ratio axsome.com|AXSM - Cumulative Company Assets

- business debt structure and liquidity details:

- company profitability and valuation multiples indicators:

AXSM - Company Net Income|Projected Future Earnings Axsome Therapeutics|AXSM - P/E Multiple|Projected Price to Earnings Axsome Therapeutics, Inc.|AXSM - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axsome|AXSM - Operating income before deduction of amortization|Earnings per share for the last twelve months Axsome Therapeutics|AXSM - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months axsome.com|AXSM - Net earnings per share growth this year|Earnings growth forecast for next year Axsome Therapeutics

Analysis of all company metrics:Axsome Therapeutics AXSM

Market expectations for Axsome Therapeutics (AXSM) often precede the current financial results of the biopharmaceutical sector. The price reflects the balance of supply and demand, determining the current cost of capital relative to support levels. By analyzing price action, an investor assesses the risk of correction and the asset's margin of safety. For a company expanding its portfolio through targeted M&A deals, quotes signal market confidence in the integration of new drugs. This makes the indicator a key measure of the business's investment attractiveness.

Analysis of competing companies